GlassScriptPhysician profile
Allyson Mecca
NPI 1346599396
$2,386.81
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,760 · 2022: $626.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $700.01 | 2021-2022 | |
| Vanda Pharmaceuticals INC. | $323.21 | 2021-2022 | |
| Alkermes, INC. | $315.36 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $212.27 | 2021-2022 | |
| Lundbeck LLC | $161.19 | 2021-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $134.53 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $114.79 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $92.21 | 2021 | |
| Avanir Pharmaceuticals, INC. | $91.53 | 2021-2022 | |
| Arbor Pharmaceuticals, INC. | $55.95 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $43.42 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $43.07 | 2021 | |
| Eisai INC. | $36.19 | 2022 | |
| Bausch Health US, LLC | $16.18 | 2021 | |
| Corium, LLC | $15.97 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $14.89 | 2021 | |
| Acadia Pharmaceuticals INC | $12.64 | 2022 | |
| Ge Healthcare | $3.40 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allyson Mecca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.